a Multicentre Phase III Study of Risk-based Treatment Intensification With Hyperfractionated Radiotherapy in Head and Neck Cancer Patients

NCT06248996 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

308

Enrollment

OTHER

Sponsor class

Conditions

Head and Neck Squamous Cell Carcinoma

Interventions

RADIATION: Hyperfractionated radiotherpy
RADIATION: Control group

Sponsor

Lund University Hospital